tion of samples and normal values. Part two is devoted to methods of analysis of biological fluids. The description of each method includes an introduction, recommended procedure or procedures, discussion, brief note on the physiological significance, and bibliography. The subject matter is treated in a simple and direct way, which is by no means complete, but the material is well selected to b...

ABO and Rh (D) groups of 6403 blood samples were assessed on an 8/9-channel autoanalyser in the Serology Department of the London Hospital; the results were independently checked at the Regional Blood Transfusion Centre, Brentwood, using the routine methods for grouping donor blood. Results of this comparative study are given and instances are described in which anomalous results or incorrect g...

Employment or Leadership: N.G. Morgenthaler, BRAHMS; A. Bergmann, BRAHMS. Consultant or Advisory Role: M.H. Brutsche, advisory boards for Pfizer (Champix, Spiriva), GlaxoSmithKline, and Novartis; C. Mueller, BRAHMS and Abbott Laboratories. Stock Ownership: A. Bergmann, BRAHMS. Honoraria: C. Mueller, Biosite, Abbott Laboratories, Roche, BRAHMS, and Siemens. Research Funding: M.T. Maeder, Swiss S...

INTRODUCTION One of the most striking developments in twentieth-century medicine has been the growing involvement of laboratory science in day-to-day medical practice. Not only are scientific laboratories employed extensively in the diagnosis and investigation of illness, but it is now commonplace to regard doctors as, in many ways, applied scientists. This is a far cry from the situation at th...

Consecutive non-replicate clinical isolates (n=191) of carbapenem non-susceptible Enterobacteriaceae were collected from 21 hospital laboratories across Italy from November 2013 to April 2014 as part of the European Survey on Carbapenemase-producing Enterobacteriaceae (EuSCAPE) project. Klebsiella pneumonia carbapenemase-producing K. pneumoniae (KPC-KP) represented 178 (93%) isolates with 76 (4...